Long-term safety and effectiveness of adalimumab in Japanese patients with Crohn’s disease: 3-year results from a real-world study

Background/Aims Crohn’s disease is a chronic disorder; therefore, it is essential to investigate long-term safety and efficacy of treatments. This study assessed the safety and effectiveness of adalimumab for up to 3 years in Japanese patients with Crohn’s disease in real-world settings. Methods Thi...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Tadakazu Hisamatsu, Yasuo Suzuki, Mariko Kobayashi, Takashi Hagiwara, Takeshi Kawaberi, Haruhiko Ogata, Toshiyuki Matsui, Mamoru Watanabe, Toshifumi Hibi
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Korean Association for the Study of Intestinal Diseases 2021-10-01
coleção:	Intestinal Research
Assuntos:	adalimumab crohn disease inflammatory bowel diseases japanese postmarketing surveillance
Acesso em linha:	http://www.irjournal.org/upload/pdf/ir-2020-00025.pdf
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!